Case studies

Case studies


Paper written by Dr. Elena Synitsina
Endocrinologist at the Clinic of Cybernetic Medicine

Clinical examples:

Case Study No.1
Case Study No.2
Case Study No.3

default altDiabetes presents a serious challenge to modern medicine. Although medical science has made considerable progress in understanding the progression of failure to metabolise carbohydrates, the means of treatment available has changed little. Insulin and the sulphonylureas are still the instrument of choice for the doctor today, just as they were at the beginning of the twentieth century. Indeed, the role of insulin therapy continues to increase. For patients with type one diabetes, it provides the only way to support glycaemic control, i.e. a normal level of glucose in the blood and so maintain life and health.

However, more and more patients with diabetes type two are also being given intensive insulin therapy, which cannot always be justified. Lowering the sugar level by increasing hyper-insulinity has a short term effect and at the same time creates a new threshold of insulin resistance – a lower sensitivity to insulin, which worsens the pathology and leads to an increase in the dose of insulin and the creation of another new level of insulin resistance. This stimulates atherogenesis, provokes increase in weight and the development of arterial hypertension. This increases the risk of developing vascular complications of diabetes such as macro-angiopathy and may lead to acute myocardia infarction, other acute problems in the cardio-vascular system and gangrene of the lower limbs. None the less the strategic issues which underlay the treatment of diabetes appear not to be on the agenda for general discussion.

Our clinic has a different approach to the treatment of diabetes. We start with the premise that the diagnostic process should be as wide and detailed as possible. In particular, before settling on a prescription for treatment, we make a careful assessment of the condition of the function of the Beta cells and the functional condition of the liver, as well as the state of the cardio-vascular system. We also take into account any other illness present, which makes for a maximal personalised approach to the individual. The main criteria for successful treatment are the lowering and normalising of the levels of glucose in the blood and the level of cholesterol and its fractions; also the normalising of weight and arterial blood pressure.

During the last year in the clinic we have conducted diagnostics on 1,500 patients with diabetes.

In the treatment clinic we observed and treated 216 diabetic patients.
  • 113 women and 103 men.

  • Average age 45 (+-2.32)

  • Diabetes Type I: 20 people

  • Diabetes Type II: 196 people

  • Average level of glycated haemoglobin before treatment: 10.1% (+-2.2)

  • Average level glycated haemoglobin 3 months after start of treatment: 3.01% lower than before (+-1.04%)